Key Development
The Drug Administration of Vietnam (DAV), operating under the Ministry of Health, has formally issued six administrative penalty decisions targeting six chief pharmacists and quality assurance managers operating across two prominent publicly listed domestic pharmaceutical groups: Cuu Long Pharmaceutical Joint Stock Company (DCL) and Nam Ha Pharmaceutical Joint Stock Company (NAMHAPHARMA).
The regulatory enforcement decrees, signed by DAV Deputy Director Nguyen Thanh Lam, impose a monetary fine of 4,000,000 VND (~$160 USD) per individual paired with an immediate compulsory remedial sanction: the absolute surrender and formal return of their Pharmacy Practice Certificates to the state licensing authority. The enforcement window mandates execution within 10 days of receipt, beyond which automated late-payment penalties (0.05% per day on uncollected balances) and mandatory civil enforcement mechanisms will be enacted.
Why It Matters
-
Core Regulatory Infraction – Non-Compliance with Continuing Pharmaceutical Education (CPE): All six penalized professionals committed an identical statutory violation under Decree 117/2020/ND-CP: Failing to complete mandatory continuing pharmaceutical education (CPE) programs within the legally binding 3-year cycle calculated from the date of initial license issuance or the most recent training certification.
-
Executive Pharmacists Targeted in the Revocation Decrees:
-
Ms. Vo Thi Tuong Khanh: QA Manager – Hard Gelatin Capsule Manufacturing Plant (Cuu Long Pharma).
-
Ms. Vo Thi Thu Trang: Wholesale Technical Pharmacist – Raw Material Capsule Unit (Cuu Long Pharma).
-
Ms. Truong Tran Trang: Technical Operations Pharmacist – Hard Gelatin Capsule Facility (Cuu Long Pharma).
-
Ms. Tran Thi Thuy Trang: Technical Wholesale Pharmacist – Pharmaceutical Manufacturing Plant (Cuu Long Pharma).
-
Ms. Tran Thi Nguyen: QA Manager – Nam Ha Pharmaceutical JSC.
-
Mr. Nguyen Manh Phu: QA Manager – Nam Ha Pharmaceutical JSC.
-
-
Operational Disruption Risks for GMP/GDP Facilities: Under the 2016 Law on Pharmacy, commercial manufacturing or wholesale facilities require a qualified Technical Manager/QA Manager possessing a valid, uncompromised Pharmacy Practice Certificate to maintain their Certificate of Eligibility for Pharmacy Business. Revoking these certificates exposes both plants to operational compliance risks.
Healthcare Insight Analysis
From the perspective of Healthcare Insight, the DAV’s decision to penalize and revoke the licenses of senior pharmacists across Cuu Long Pharma and Nam Ha Pharma signals that Rigorous Post-Market Human Resource Compliance has become a central focus for Vietnamese regulators.
For years, the statutory mandate requiring Continuing Pharmaceutical Education (CPE) every three years under Article 9 of the 2016 Law on Pharmacy has been intermittently deprioritized by both clinical and industrial pharmacists. Technical managers within Good Manufacturing Practice (GMP) facilities often assumed that internal corporate training or years of facility experience superseded formal state-mandated CPE credentials, resulting in missed re-certification cycles.
The operational implications for Cuu Long Pharma and Nam Ha Pharma are significant:
-
GMP/GDP Quality Assurance Vulnerabilities: Quality Assurance (QA) and Technical Managers serve as the final compliance gates authorizing batch releases for raw materials (such as hard gelatin capsules—the primary input for billions of solid oral dosage forms) and finished pharmaceuticals. Having their practice certificates invalidated subjects batch records released during non-compliant periods to potential regulatory review.
-
Exposing Corporate Governance Deficits in Domestic Big Pharma: Simultaneous non-compliance across multiple senior technical personnel within the same corporate structure indicates that internal Legal and HR compliance tracking systems at Cuu Long and Nam Ha lacked automated oversight regarding license expiration dates and mandatory training obligations.
This coordinated administrative crackdown, paired with parallel investigations by the Ho Chi Minh City Department of Health Inspectorate targeting falsified licensing dockets, demonstrates the Ministry of Health’s commitment to enforcing human resource compliance standards aligned with the Vietnamese Pharmacopoeia VI and international quality frameworks.
Market Implications
-
Surging Demand for Certified CPE Training Programs: This regulatory enforcement will create a domino effect, compelling thousands of pharmacists across GMP manufacturing plants, retail pharmacy chains (such as Long Chau, An Khanh, Pharmacity), and wholesale distribution networks to audit their 3-year CPE timelines and enroll in accredited training modules.
-
Institutionalization of HR Compliance Software in Pharma Groups: Pharmaceutical enterprises will incorporate CPE compliance into mandatory internal KPIs while deploying automated tracking platforms to notify technical managers six months prior to statutory licensing deadlines.
-
Rigorous Workforce Auditing During State GMP/GDP Inspections: DAV and regional Department of Health audit teams conducting periodic re-evaluations of GMP plants and GDP warehouses will integrate CPE compliance verification as a key audit parameter during facility inspections.
Regulatory Enforcement Ledger: Drug Administration of Vietnam (August 2026)
| Penalized Pharmacist | Designated Role | Affiliated Enterprise / Plant | Statutory Violation Profile | Administrative Fine & Remedial Mandate |
| Ms. Vo Thi Tuong Khanh | QA Manager | Hard Gelatin Capsule Facility (Cuu Long) | Failed to complete 3-year mandatory CPE program. | 4M VND Fine; compulsory surrender of Practice Certificate within 10 days. |
| Ms. Vo Thi Thu Trang | Wholesale Tech Lead | Raw Material Capsule Unit (Cuu Long) | Failed to complete 3-year mandatory CPE program. | 4M VND Fine; compulsory surrender of Practice Certificate within 10 days. |
| Ms. Truong Tran Trang | Technical Lead | Hard Gelatin Capsule Facility (Cuu Long) | Failed to complete 3-year mandatory CPE program. | 4M VND Fine; compulsory surrender of Practice Certificate within 10 days. |
| Ms. Tran Thi Thuy Trang | Wholesale Tech Lead | Pharmaceutical Plant (Cuu Long) | Failed to complete 3-year mandatory CPE program. | 4M VND Fine; compulsory surrender of Practice Certificate within 10 days. |
| Ms. Tran Thi Nguyen | QA Manager | Nam Ha Pharmaceutical JSC | Failed to complete 3-year mandatory CPE program. | 4M VND Fine; compulsory surrender of Practice Certificate within 10 days. |
| Mr. Nguyen Manh Phu | QA Manager | Nam Ha Pharmaceutical JSC | Failed to complete 3-year mandatory CPE program. | 4M VND Fine; compulsory surrender of Practice Certificate within 10 days. |